SecBot SecBot
Insider Cluster (2 insiders) ·Filed Mar 16, 2026

IRD

Opus Genetics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $146K total
Actionable Insight • Neutral

Monitor for additional insider selling in the next quarter; while this cluster is small and likely routine, continued sales near this level or above could signal waning confidence.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
IRD ▼ -22.35% at T+60d
NEUTRAL call -22.35% · α vs SPY -32.83% · entry $5.19 → $4.03
Entry = T+0 close
Mar 15, 2026
via day close
T+1d
-7.51%
call -7.51% · α -7.79%
$4.80
settled 8mo ago
T+5d
-11.56%
call -11.56% · α -9.52%
$4.59
settled 7mo ago
T+20d
+6.94%
call +6.94% · α +3.16%
$5.55
settled 7mo ago
T+60d
-22.35%
call -22.35% · α -32.83%
$4.03
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Two Opus Genetics executives, including the CEO and Chief Scientific & Development Officer, sold shares in the past week, totaling $146,373 in open-market transactions. The sales represent a small fraction of the company's market cap and appear to be routine individual transactions rather than a coordinated move.

Key Financial Metrics

Direction
selling
Total Value
$146.4K
Insiders
2

Key Facts

  • CEO George Magrath sold 24,438 shares at $5.2102, totaling $127,327 in open-market sale.
  • Chief Scientific & Development Officer Ashwath Jayagopal sold 3,719 shares at $5.1213, totaling $19,046 in open-market sale.
  • Total insider sales in the past 7 days: $146,373 across two transactions.
  • All transactions were open-market sales (S code), not related to grants, awards, or tax events.

Financial Impact

$146,373 in total open-market sales by two C-suite executives

insider ownershipmarket sentiment

Risk Factors

  • Perception risk if further insider selling follows, especially ahead of key clinical or financing events.
  • Concentration risk given the company's small market cap and reliance on executive leadership in a high-stakes gene therapy development space.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (2 trades, 7d window)cluster-IRD-1773864664557
27 reports for IRD
Performance horizon
50% Hit rate @ T+60 2 of 4 directional calls Went positive at some point 5 of 8 best @ T+60▲ +28.19%May 12, 2026
Filters
Rows
Reports for IRD — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G
NEUTRAL ★ 3/10
$3.32awaiting T+60—$3.46 (+4.22%)
Oct 27, 2026
today
Insider Cluster
NEUTRAL ★ 2/10
$3.32awaiting T+60—$3.46 (+4.22%)
Oct 23, 2026
4d ago
144
NEUTRAL ★ 2/10
$3.32awaiting T+60—$3.46 (+4.22%)
Oct 21, 2026
6d ago
8-K
NEUTRAL ★ 2/10
$3.82awaiting T+60—$3.46 (−9.42%)
Oct 15, 2026
12d ago
8-K
BULLISH ★ 6/10
$3.84awaiting T+60—$3.46 (−9.90%)
Oct 15, 2026
12d ago
Press Release
BULLISH ★ 6/10
$3.84awaiting T+60—$3.46 (−9.90%)
Sep 22, 2026
5w ago
Institutional Cluster
NEUTRAL ★ 3/10
$5.16awaiting T+60—$3.46 (−32.95%)
Sep 11, 2026
6w ago
8-K
BULLISH ★ 7/10
$6.04awaiting T+60—$3.46 (−42.72%)
Sep 9, 2026
6w ago
8-K
BULLISH ★ 7/10
$5.73awaiting T+60—$3.46 (−39.62%)
Sep 2, 2026
7w ago
Press Release
NEUTRAL ★ 5/10
$4.45awaiting T+60—$3.46 (−22.25%)
Showing 10 of 27

US Market Status

Market Closed — Opens Thu (11h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 18, 2026